Cantrixil

N/A

Report date: 2025/03/26 20:01:25
NME

Base Information

Drug NameCantrixil
Drug Alias NameTRXE-002-1TRXE-002TRX-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionElectron transport chain complex proteins inhibitorsTubulin polymerisation inhibitors
TargetsElectron transport chain complex proteinsTubulin
Therapy Area/IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKazia Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVivesto ABKazia Therapeutics LtdOasmia Pharmaceutical Ab
Active IndicationsN/A
Inactive IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A